chartexchange

NBIO
NASCENT BIOTECH INC
stockOTC

EODNov 18, 2026
0.0001USD-75.000%(-0.0003)115,599
Loading…
Loading…
Healthcare
Biotechnology
HQ
North Palm Beach, FL, USA
Previous Close
$0.00
Beta
28.50
52-Week High
$0.08 2026-01-26
52-Week Low
$0.00 2026-11-18
SMA 50
$0.00
SMA 200
$0.02
Avg. Vol 10D
52,662
Avg. Vol 30D
58,262
Avg. Vol 90D
60,763
Relative Vol
1.98
172.20M
99.45M
5,195
NBIO Profile

nascent biotech, inc. (otcmkts:nbio) is a public company, formed in march 2014, to continue development of pritumumab, a human monoclonal antibody created by a number of leading scientists who have developed various monoclonal antibodies and cytokine treatments for oncology indications. pritumumab recognizes a unique and proprietary antigen expressed on the surface of cancer cells and is being developed to treat brain and pancreatic cancers, both unmet clinical needs. nbio's clinical premise is that the most effective way to treat disease is to modulate (boost or suppress) the human body's natural ability to generate an immune response. often referred to as "immunotherapy", the scientific approach is based upon two discrete types of regulatory molecules, monoclonal antibodies and cytokines that can be combined to maximize therapeutic effectiveness in a variety of diseases. monoclonal antibodies (mabs) are naturally occurring proteins that bind with exquisite specificity to molecular st

NBIO Performance
PeriodPriceDateChangeBeta
1W0.002026-11-12-75.00%0.000
1M0.002026-10-14-50.00%-59.002
3M0.002026-08-13-66.67%-0.814
6M0.002026-05-20-66.67%43.759
1Y0.002025-11-24-97.67%28.500
2Y0.052024-11-19-99.81%—
5Y0.072021-11-19-99.86%-1.435
NBIO Stock Summary

NASCENT BIOTECH INC (OTC:NBIO) stock price today is $0.00, and today's volume is 115,599. NBIO is down 75.000% today. The 30 day average volume is 58,262. NBIO market cap is $17,220 with 172.20M shares outstanding.